COVID 19 in Cancer Afflicted Children - Impact and Lessons Learnt So Far
Priti S Mehta*
Pediatric Hematologist-Oncologist, Associate Professor, Sir J.J. Hospital, Saifee Hospital, H.N. Reliance Hospital, S.L. Raheja Hospital, India
*Corresponding Author: Priti S Mehta, Pediatric Hematologist-Oncologist, Associate Professor, Sir J.J. Hospital, Saifee Hospital, H.N. Reliance Hospital, S.L. Raheja Hospital, India.
May 19,2021; Published: May 31, 2021
COVID 19 has affected Cancer afflicted children in multiple ways. Postponement of chemotherapy, shortage of beds, delayed elective surgeries, radiotherapy, contracting Covid infection due to Immunosuppressed state, shortage of blood and blood products are few of them. However, it has also taught us certain lessons as to continue chemotherapy in cancers which affect the long term prognosis. The concept of chronic viral shedders, non-requirement of repeat RT-PCR testing, avoiding use of colony stimulating factors during active infection are some of the lessons learnt so far. The fact that children per se and that includes children with cancer too are not affected seriously till date in this pandemic brings some solace to the treating physicians.
Keywords: COVID 19; Cancer; Oncology
- Graetz D., et al. “Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study”. Lancet Child and Adolescent Health 5 (2021): 332-340.
- Vasquez L., et al. “Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America”. Lancet Oncology 21 (2020): 753-755.
- Mohammad Alshahrani., et al. “The Impact of COVID-19 Pandemic in Children with Cancer: A Report From Saudi Arabia”. Health Services Insights 13 (2020): 1178632920984161.
- Vasquez L., et al. “Catalyzing childhood cancer care in Peru after one year of the Global Initiative for Childhood Cancer”. JCO Global Oncology 7 (2021): 187-189.
- Hrusak O., et al. “Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patient on anticancer treatment”. European Journal of Cancer 132 (2020): 11-16.
- Andre N., et al. “COVID-19 in pediatric oncology from French pediatric oncology and hematology centers: high risk of severe forms?” Pediatric Blood Cancer7 (2020): e28392.
- de Rojas T., et al. “COVID-19 infection in children and adolescents with cancer in Madrid”. Pediatric Blood Cancer7 (2020): e28397.
- Farid Boulad MD., et al. “COVID-19 in Children with Cancer in New York City”. JAMA Oncology 13 (2020): e202028.
- Saroha M and Moulik NR. “COPING with CORONA: A developing country perspective on managing children with cancer during COVID-19 Pandemic”. Cancer Research, Statistics, and Treatment 3 (2020): 97-101.
- “Considerations in Adults and Children with Cancer”.
- National Comprehensive Cancer Network. “NCCN hematopoietic growth factors: short-term recommendations specific to issues with COVID-19 (SARS-CoV-2)” (2020).
- American Society for Radiation Oncology. “COVID-19 clinical guidance” (2020).
- Yahalom J., et al. “ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic”. Blood21 (2020): 1829-1832.
- Shah V., et al. “Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King’s College Hospital experience”. British Journal of Haematology (2020).